Company: HURA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-281539
Chunk: 0

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 0
---
TuHURA Biosciences, Inc. 

Condensed Consolidated Balance Sheets

     September 30,

     December 31,

     2025

     2024

     (Unaudited)

     Assets

     Current Assets:

     Cash and cash equivalents
      
     $
     2,697,416

     $
     12,657,178

     Deposits, planned business acquisition (note 1)

     -

     5,994,503

     Other current assets

     806,429

     958,708

     Total Current Assets

     3,503,845

     19,610,389

     Property and equipment, net

     295,332

     123,366

     Operating right-of-use assets

     82,707

     199,160

     Other noncurrent assets

     -

     33,769

     Goodwill

     13,554,164

     -

     In-process research and development

     8,261,000

     -

     Total Assets
      
     $
     25,697,048

     $
     19,966,684

     Liabilities and Stockholders' Equity

     Current Liabilities:

     Accounts payable and accrued expenses
      
     $
     5,480,577

     $
     5,170,166

     Note Payable to former Kineta employees

     493,386

     -

     Holdback liability, payable in shares

     2,775,795

     -

     Lease liabilities, current

     84,346

     159,844

     Total Current Liabilities

     8,834,104

     5,330,010

     Long-term Liabilities:

     Lease liability, long term

     -

     42,698

     Other long-term liabilities

     84,985

     -

     Total Liabilities

     8,919,089

     5,372,708

     Stockholders' Equity:

     Preferred Stock Series A (assumed in Kintara merger); $1.00 par value, 278,530 shares   outstanding as of September 30, 2025 and December 31, 2024

     278,530

     278,530

     Common stock, $0.001 par value, 200,000,000 and